Avivagen Announces the Issuance of Shares
May 02, 2018 16:30 ET
|
Avivagen Inc.
OTTAWA, May 02, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products...
Avivagen Announces its Attendance at the Bloom Burton & Co. Healthcare Investor Conference
May 01, 2018 16:30 ET
|
Avivagen Inc.
OTTAWA, May 01, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products...
Avivagen Announces OxC-beta™ Purchase Order with New Customer
April 25, 2018 06:30 ET
|
Avivagen Inc.
OTTAWA, April 25, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”) is a life sciences corporation focused on developing and commercializing...
Avivagen Announces the Issuance of Stock Options
April 13, 2018 16:15 ET
|
Avivagen Inc.
OTTAWA, April 13, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products...
Avivagen Announces Results from Its Annual General Meeting
April 10, 2018 16:30 ET
|
Avivagen Inc.
OTTAWA, April 10, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products...
Avivagen Announces an Amendment to its Stock Option Plan
April 05, 2018 06:30 ET
|
Avivagen Inc.
OTTAWA, April 05, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products...
Avivagen Announces Continued Growth and Adoption in the Commercial Use of OxC-beta™ Livestock in the Philippines
March 26, 2018 06:30 ET
|
Avivagen Inc.
OTTAWA, March 26, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products...
Cesar Millan’s Highly Recommended Vivamune™ Scheduled for Global Pet Expo Debut
March 19, 2018 06:30 ET
|
Avivagen Inc.
OTTAWA, March 19, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Company”), a life sciences innovation company with a series of patent protected products that...
Avivagen Announces Approval from TSX Venture Exchange for Extension of Warrants
March 12, 2018 06:30 ET
|
Avivagen Inc.
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. OTTAWA, March 12, 2018 ...
Avivagen Announces CEO Update and January 31, 2018 Financial First Quarter Results
February 27, 2018 06:30 ET
|
Avivagen Inc.
OTTAWA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Company”), a life sciences innovation company with a series of patent protected products that...